Mathias Lalika

Biographic Data

ID7766866
NAMEMathias Lalika
GIVEN NAMESMathias
FAMILY NAMELalika
SIGNATURELALIKA M
AFFILIATIONSMayo Clinic
ORCID0000-0003-0229-9942
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2025
H-INDEX0

  • Community-based participatory design of a decade

    Open AccessLaprincess C Brewer, Mathias Lalika et al.ARTICLEFrontiers in Public Health2025

    The FAITH! (Fostering African-American Improvement in Total Health) Cardiovascular Health and Wellness Program is more than a decade-long community-based participatory research initiative aimed at addressing cardiovascular health disparities among African-Americans in Minnesota. Founded in 2013, the program employs a culturally tailored, community-driven approach by partnering with African-American faith communities to promote cardiovascular heal…

  • A qualitative study of academic bullying among junior doctors in Sierra Leone

    Open AccessFatima Jalloh, Abdul Karim Bah et al.ARTICLEBMC Public Health2025

    Academic bullying at USLTHC is systemic, culturally rationalised, and exacerbated by resource constraints. Embedding enforceable anti-bullying policies, structured faculty-development, and accessible mental-health services is essential to protect trainees and protect Sierra Leone's evolving health-workforce

  • Barriers to global engagement for African researchers

    Open AccessBamba Gaye, Nzechukwu M Isiozor et al.ARTICLEJournal of Global Health2024

    African researchers continue to face numerous barriers that limit the global dissemination and advancement of their research. These include high open-access publication fees, requirements for publishing in high-impact journals, inability to attend or host international conferences, and limited access to published papers and resources. In this viewpoint, we focus on the specific challenge of attending [...]

  • Interferon-based agents for current and future viral respiratory infections

    Open AccessAldina Mešić, Emahlea K Jackson et al.ARTICLEPLOS Global Public Health2022

    The interferon (IFN) system is a potent line of defense against viral infections. IFN-based agents already tested may be of use in COVID-19 or future viral respiratory outbreaks. Here we review the comparative efficacy, safety/tolerability, and future potential of IFN-based therapeutics. We reviewed human studies in which IFN or IFN pathway-interacting agents were used for viral respiratory infections. We identified 977 articles, of which 194 wer…